The Fusion CX IPO is a closed mainboard Bookbuilding offer (Fresh capital cum OFS) that opened on 14 October 2026. The Fusion CX IPO closed on 16 October 2026, with an issue price of ₹289 per share. The Fusion CX IPO has a face value of ₹1 and a lot size of 51 shares. The Fusion CX IPO size aggregates up to ₹702 crore, listing on NSE & BSE on 22 October 2026. The Fusion CX IPO allotment is expected on 19 October 2026.
On the financial front, the Fusion CX IPO reported revenue of ₹504 crore for 30 Jun 2026, compared with ₹1,852 crore for 31 Mar 2026. The Fusion CX IPO PAT was ₹56 crore against ₹170 crore. The Fusion CX IPO EBITDA stood at ₹95 crore with a 20.03% margin. The Fusion CX IPO net worth as of 30 Jun 2026 was ₹25 crore.
Always verify The Fusion CX IPO details and GMP data with the official offer document before investing in the Fusion CX IPO.
Financial Summary
Amount in ₹ Crore
Metric
30 Jun 2026
31 Mar 2026
31 Mar 2025
Total Assets
1,368
1,385
1,143
Revenue
504
1,852
1,352
PAT
56
170
74
EBITDA
95
330
198
Net Worth
25
27
17
Reserves
607
548
346
Total Borrowing
48
59
82
Fusion CX IPO Financials FAQs
Revenue of Fusion CX (Amount in ₹ Crore) — 30 Jun 2026: 504; 31 Mar 2026: 1,852; 31 Mar 2025: 1,352. Profit after tax (PAT) — 30 Jun 2026: 56; 31 Mar 2026: 170; 31 Mar 2025: 74.
EBITDA of Fusion CX (Amount in ₹ Crore) — 30 Jun 2026: 95; 31 Mar 2026: 330; 31 Mar 2025: 198. The EBITDA margin is 20.03%.
Total assets — 30 Jun 2026: 1,368; 31 Mar 2026: 1,385; 31 Mar 2025: 1,143. Net worth — 30 Jun 2026: 25; 31 Mar 2026: 27; 31 Mar 2025: 17. Reserves & surplus — 30 Jun 2026: 607; 31 Mar 2026: 548; 31 Mar 2025: 346. (Amount in ₹ Crore)
Total borrowing of Fusion CX (Amount in ₹ Crore) — 30 Jun 2026: 48; 31 Mar 2026: 59; 31 Mar 2025: 82. Debt-to-equity ratio: 0.51.
The financials shown for Fusion CX IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.
